Angiotensin II receptor type 2, also known as the AT2 receptor is a protein that in humans is encoded by the AGTR2gene.[5]
Function
Angiotensin II is a potent pressorhormone and a primary regulator of aldosterone secretion. It is an important effector controlling blood pressure and volume in the cardiovascular system. It acts through at least two types of receptors termed AT1 and AT2. AGTR2 belongs to a family 1 of G protein-coupled receptors. It is an integral membrane protein. It plays a role in the central nervous system and cardiovascular functions that are mediated by the renin–angiotensin system. This receptor mediates programmed cell death (apoptosis). Consistent with its apoptotic function, angiotensin II receptor type II also opposes cell proliferation, as demonstrated by its antagonism of MAPK activity in cardiac fibroblasts during interstitial fibrosis.[6] In adults, it is highly expressed in myometrium with lower levels in adrenal gland and fallopian tube. It is highly expressed in fetal kidney and intestine. The human AGTR2 gene is composed of three exons and spans at least 5 kb. Exons 1 and 2 encode for 5' untranslated mRNA sequence and exon 3 harbors the entire uninterrupted open reading frame.[5]
Stimulation of AT2 by the selective agonist CGP 42112A increases mucosal nitric oxide production.[7]
Gene
Angiotensin II receptor type 2 (AGTR2) gene is a protein coding gene responsible for encoding AGTR2, the integral membrane protein that binds to two different G-protein coupled receptors. AGTR2 has recently been discovered to play a role in modifying lung disease. This receptor functions to mediate signaling in lung fibrosis and regulate nitric oxide synthase expression in pulmonary endothelium. [8] AGTR2 has recently been prescribed as a target for lung inflammation therapy in cases of cystic fibrosis (CF). The X-chromosome region associated with CF lung disease is located in a non-coding region 3′ of the AGTR2 gene. The modification effect is likely due to variation in gene regulation rather than a change in protein coding sequence.
Variants at the X-chromosome locus containing AGTR2 gene were identified as significantly associating with lung function in patients with cystic fibrosis. Genetically modified mouse studies determined that absence of the AGTR2 gene normalized pulmonary function indicators in two independent CF mouse models. Furthermore, pharmacological antagonism of AGTR2 signaling improved lung function in CF mice to near wild-type levels. Manipulation of the angiotensin-signaling pathway to reduce AGTR2 signaling may be translatable for the treatment or prevention of CF.[9]
Interactions
Angiotensin II receptor type 2 has been shown to interact with MTUS1.[10]
de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (September 2000). "International union of pharmacology. XXIII. The angiotensin II receptors". Pharmacological Reviews. 52 (3): 415–72. PMID10977869.
Regitz-Zagrosek V, Neuss M, Warnecke C, Holzmeister J, Hildebrandt AG, Fleck E (1997). "Subtype 2 and atypical angiotensin receptors in the human heart". Basic Research in Cardiology. 91 (Suppl 2): 73–7. doi:10.1007/bf00795366. PMID8957548. S2CID12357519.
Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG (December 2001). "Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide". American Journal of Physiology. Heart and Circulatory Physiology. 281 (6): H2337–65. doi:10.1152/ajpheart.2001.281.6.H2337. PMID11709400. S2CID41296327.
Takayanagi R, Ohnaka K, Sakai Y, Nakao R, Yanase T, Haji M, Inagami T, Furuta H, Gou DF, Nakamuta M (March 1992). "Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor". Biochemical and Biophysical Research Communications. 183 (2): 910–6. doi:10.1016/0006-291X(92)90570-B. PMID1550596.
Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK (October 1995). "Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice". Nature. 377 (6551): 744–7. doi:10.1038/377744a0. PMID7477266. S2CID4335142.
Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T (October 1995). "Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor". Nature. 377 (6551): 748–50. Bibcode:1995Natur.377..748I. doi:10.1038/377748a0. PMID7477267. S2CID4277560.
Lazard D, Briend-Sutren MM, Villageois P, Mattei MG, Strosberg AD, Nahmias C (1995). "Molecular characterization and chromosome localization of a human angiotensin II AT2 receptor gene highly expressed in fetal tissues". Receptors & Channels. 2 (4): 271–80. PMID7719706.
Martin MM, Elton TS (April 1995). "The sequence and genomic organization of the human type 2 angiotensin II receptor". Biochemical and Biophysical Research Communications. 209 (2): 554–62. doi:10.1006/bbrc.1995.1537. PMID7733925.
Chassagne C, Beatty BG, Meloche S (January 1995). "Assignment of the human angiotensin II type 2 receptor gene (AGTR2) to chromosome Xq22-q23 by fluorescence in situ hybridization". Genomics. 25 (2): 601–3. doi:10.1016/0888-7543(95)80072-T. PMID7790004.
Martin MM, Su B, Elton TS (November 1994). "Molecular cloning of the human angiotensin II type 2 receptor cDNA". Biochemical and Biophysical Research Communications. 205 (1): 645–51. doi:10.1006/bbrc.1994.2714. PMID7999093.
Tsuzuki S, Ichiki T, Nakakubo H, Kitami Y, Guo DF, Shirai H, Inagami T (May 1994). "Molecular cloning and expression of the gene encoding human angiotensin II type 2 receptor". Biochemical and Biophysical Research Communications. 200 (3): 1449–54. doi:10.1006/bbrc.1994.1613. PMID8185599.
Servant G, Boulay G, Bossé R, Escher E, Guillemette G (May 1993). "Photoaffinity labeling of subtype 2 angiotensin receptor of human myometrium". Molecular Pharmacology. 43 (5): 677–83. PMID8502225.
Katsuya T, Horiuchi M, Minami S, Koike G, Santoro NF, Hsueh AJ, Dzau VJ (March 1997). "Genomic organization and polymorphism of human angiotensin II type 2 receptor: no evidence for its gene mutation in two families of human premature ovarian failure syndrome". Molecular and Cellular Endocrinology. 127 (2): 221–8. doi:10.1016/S0303-7207(97)04011-2. PMID9099917. S2CID39436241.
Knowle D, Ahmed S, Pulakat L (February 2000). "Identification of an interaction between the angiotensin II receptor sub-type AT2 and the ErbB3 receptor, a member of the epidermal growth factor receptor family". Regulatory Peptides. 87 (1–3): 73–82. doi:10.1016/S0167-0115(99)00111-1. PMID10710290. S2CID19101120.
"Angiotensin Receptors: AT2". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Archived from the original on 2016-06-16. Retrieved 2008-11-25.